- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Audientes A/S: Bankruptcy Order Issued Against the Company | 2 | Cision News | ||
| AUDIENTES Aktie jetzt für 0€ handeln | |||||
| 16.12. | Audientes A/S: Independent Board Member Hiroshi Maeda Resigns | 1 | Cision News | ||
| 11.12. | Audientes A/S: Update on bankruptcy petition and court proceedings | 1 | Cision News | ||
| 11.12. | Audientes A/S: Bankruptcy petition filed against the Company | 2 | Cision News | ||
| 11.12. | Spotlight Stock Market: Market Notice 221/25 - Trading halt in Audientes A/S | 1 | Cision News | ||
| 10.12. | Audientes A/S: Independent Board Member Wendi Ma Resigns | 1 | Cision News | ||
| 30.11. | Audientes A/S: Q3 2025 Financial Report | 3 | Cision News | ||
| 19.11. | Audientes A/S: New date for Q3 2025 Financial Report | 2 | Cision News | ||
| 02.09. | Spotlight Stock Market: Market notice 165/25 - Audientes A/S's share, AUDNTS is moved to the Observation List | 1 | Cision News | ||
| 29.08. | Audientes A/S: Q2/Half-year 2025 Financial Report | 2 | Cision News | ||
| 16.07. | Audientes A/S: Flagging notification | 2 | Cision News |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BETA BIONICS | 31,690 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,000 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,200 | 0,00 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| HEARTFLOW | 31,250 | 0,00 % | Hedge Fund and Insider Trading News: Ken Griffin, Warren Buffett, Israel Englander, Viking Global, Point72 Asset Management, Heartflow Inc (HTFL), Teva Pharmaceutical Industries Ltd (TEVA), and More | ||
| PRIVIA HEALTH GROUP | 24,020 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| PROGYNY | 26,970 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 34,250 | 0,00 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| ADAPTHEALTH | 10,290 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| FRESENIUS MEDICAL CARE | 40,840 | +0,10 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,670 | -0,16 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Siemens Healthineers mit "Outperform" und einem Kursziel von 52,90 Euro in die Bewertung wieder aufgenommen. Nach einem für die... ► Artikel lesen | |
| FRESENIUS | 48,650 | +0,21 % | DAX tiefer, China schwach: US-Arbeitsmarkt, Rheinmetall, Zalando, Fresenius, Nordex, Pfizer ... | Der DAX hat am Montag einen knappen Gewinn über die Ziellinie retten können. Aus dem Handel ging er mit einem Plus von 0,2 Prozent auf 24.229,91 Zählern. Zum Start in den Dienstag dürfte er zunächst... ► Artikel lesen | |
| GENEDX | 139,93 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| BILLIONTOONE | 96,29 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 41,405 | +4,98 % | Castle Biosciences, Inc.: Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| LUMEXA IMAGING | 17,945 | 0,00 % | Lumexa Imaging Announces Pricing of Initial Public Offering | RALEIGH, N.C., Dec. 10, 2025 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") announced today the pricing of its initial public offering of 25,000... ► Artikel lesen |
Das Unternehmen AUDIENTES A/S kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AUDIENTES A/S finden Sie auf Wallstreet Online.